ID: ALA3260674

Max Phase: Preclinical

Molecular Formula: C13H12N2O3S2

Molecular Weight: 308.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)/C=C/CNC(=O)c1csc(-c2cccs2)n1

Standard InChI:  InChI=1S/C13H12N2O3S2/c1-18-11(16)5-2-6-14-12(17)9-8-20-13(15-9)10-4-3-7-19-10/h2-5,7-8H,6H2,1H3,(H,14,17)/b5-2+

Standard InChI Key:  AOAIDNVQWHLPPM-GORDUTHDSA-N

Associated Targets(non-human)

Human rhinovirus A protease 1343 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.38Molecular Weight (Monoisotopic): 308.0289AlogP: 2.33#Rotatable Bonds: 5
Polar Surface Area: 68.29Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.43CX LogD: 2.43
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.68Np Likeness Score: -1.30

References

1. Kathman SG, Xu Z, Statsyuk AV..  (2014)  A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.,  57  (11): [PMID:24870364] [10.1021/jm500345q]

Source